Diagnosis, management, and treatment of hepatitis C

Authors

  • Doris B. Strader,

    1. Fletcher Allen Health Care University of Vermont College of Medicine, Burlington, VA
    Search for more papers by this author
  • Teresa Wright,

    1. University of California, San Francisco School of Medicine, San Francisco, CA
    2. Veterans Affairs Medical Center, San Francisco, CA
    Search for more papers by this author
    • Dr. Wright serves on the advisory boards of Hoffmann-La Roche and Amgen, receives research support from Hoffmann-La Roche, Orthobiotec, and Schering Plough Research Institute, and is on the Hoffmann-La Roche Speakers Bureau.

  • David L. Thomas,

    1. Johns Hopkins University School of Medicine, Baltimore, MD
    Search for more papers by this author
    • Dr. Thomas serves on the advisory board for Roche Pharmaceuticals.

  • Leonard B. Seeff

    Corresponding author
    1. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    2. Veterans Affairs Medical Center, Washington, DC
    Current affiliation:
    1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health 31A Center Drive, Room 9A27, Bethesda, MD 20892
    • American Association for the Study of Liver Diseases, 1729 King Street, Suite 200, Alexandria, VA 22314
    Search for more papers by this author
    • fax: 301-480-7926


  • All AASLD Practice Guidelines are updated annually. If you are viewing a Practice Guideline that is more than 12 months old, please visit www.aasld.org for an update in the material.

Ancillary